Canara Robeco Mutual Fund bought 6,26,000 shares of Biocon Limited for ₹25.04 Cr at ₹400.00 apiece in a block deal.
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
Joint venture between Canara Bank and Robeco of Netherlands. Manages over Rs 1.5 lakh crore. Canara Robeco Equity Hybrid Fund and Canara Robeco Emerging Equities are among its best-regarded offerings with long consistent track records. Backed by the Canara Bank network for distribution across Tier 2 and Tier 3 India.
